Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Bioorg Med Chem Lett. 2016 Mar 25;26(17):4358–4361. doi: 10.1016/j.bmcl.2016.03.083

A two-step strategy for the preparation of 6-deoxy-L-sorbose

Liuqing Wen a, Kenneth Huang a, Yuan Zheng a, Yunpeng Liu a, He Zhu a, Peng George Wang a,*
PMCID: PMC5067164  NIHMSID: NIHMS807267  PMID: 27485385

Abstract

A two-step enzymatic strategy for the efficient and convenient synthesis of 6-deoxy-L-sorbose was reported herein. In the first reaction step, the isomerization of L-fucose (6-deoxy-Lgalactose) to L-fuculose (6-deoxy-L-tagatose) catalyzed by L-fucose isomerase (FucI), and the epimerization of L-fuculose to 6-deoxy-L-sorbose catalyzed by D-tagatose 3-epimerase (DTE) were coupled with the targeted phosphorylation of 6-deoxy-L-sorbose by fructose kinase from human (HK) in a one-pot reaction. The resultant 6-deoxy-L-sorbose 1-phosphate was purified by silver nitrate precipitation method. In the second reaction step, the phosphate group of the 6-deoxy-L-sorbose 1-phosphate was hydrolyzed with acid phosphatase (AphA) to produce 6-deoxy-L-sorbose in 81% yield with regard to L-fucose.

Keywords: 6-deoxy-L-sorbose, Enzymatic synthesis, Phosphorylation, Dephosphorylation, One-pot multienzyme

Graphical abstract

graphic file with name nihms-807267-f0001.jpg


Rare sugars are defined as monosaccharides that only naturally occur in small amounts.1 According to the classification by the International Society of Rare Sugars (ISRS), only seven monosaccharides (D-xylose, D-ribose, L-arabinose, D-galactose, D-glucose, D-mannose, and D-fructose) are present in substantial enough quantities to be considered common sugars, whereas all others belong to the “rare sugars” classification.2 Rare sugars have garnered much attention over the past decades due to their potential applications in pharmaceutical, medicinal, and synthetic chemistry.3-6 For example, L-ribose can be used as a building block for L-enantiomers of nucleoside analogues against cancers and viral infections.7 D-psicose is used as a precursor for the synthesis of xylosylpsicoses, which are promising candidates for prebiotics, cosmetics and therapeutic uses.8 In addition, “rare sugars” are also well known for their uses as low calorie sweeteners and functional food bulking agents due to the slow and incomplete absorption of these sugars by the human body.3,9-12 As evidenced, D-psicose has approximately 70% of the sweetness but only 0.3% of the energy calories of sucrose.10,13 Nevertheless, the study of rare sugars have been hindered largely by their limited availability.

Izumori and co-workers have established a beautiful strategy termed “Izumoring” for rare sugar synthesis, a method by which most of rare sugars have been produced through isomerization, epimerization, oxidization or reduction reactions.14 However, this strategy tends to suffer from low yield, complicated conversion processes or a tedious purification steps. To address these problems, we recently developed a convenient, efficient and cost- effective platform for ketose synthesis, by which 10 non-readily available ketopentoses (L-ribulose, D-xylulose, D-ribulose, and L-xylulose) and ketohexoses (D-tagatose, D-sorbose, D-psicose, L-tagatose, L-fructose and L-psicose) were prepared from common and inexpensive starting materials with both high yield and purity without having to undergo a tedious isomer separation step.15 The basic concept of this strategy is based on a “phosphorylation→dephosphorylation” cascade reaction. Thermodynamically unfavorable conversions were combined with targeted phosphorylation reactions by substrate-specific kinases to drive the conversions towards the formation of the desired ketoses. The remaining phosphate donor (ATP) and phosphorylation reaction byproduct (ADP) were selectively removed by silver nitrate precipitation method to afford the intermediate of sugar phosphate. Afterwards, the phosphate group was hydrolyzed with phosphatase to afford the desired product. Subsequently, L-rhamnulose and L-fuculose were also produced by using this strategy, in which both deoxy ketoses were obtained in an yield exceeding 80%.16 In this work, 6- deoxy L-sorbose was synthesized from L-fucose using the similar strategy.

6-deoxy-L-sorbose can serve as a precursor of furaneol (4-Hydroxy-2,5-dimethyl-3(2H)-furanone), an important compound in the food industry for its caramerl-like flavor used in food industry.17 Moreover, 6-deoxy-L-sorbose is also the starting material for the preparation of 6-deoxy-L-gulose and 6-deoxy-L-idose.18 The majority of the potential applications of 6-deoxy-L-sorbose have not been fully investigated due to its relative scarcity. Enzymatic synthesis by the condensation of dihydroxyacetone phosphate (DHAP) and L-lactaldehyde employing aldolase has been the primary method for 6-deoxy-L-sorbose preparation (Scheme 1, A), in which 6-deoxy-L-sorbose was obtained in 56% yield.19 Hecquet and co-workers found that 6-deoxy-L-sorbose could also be prepared from 2,3-dihydroxybutyraldehyde and hydroxypyruvate by using transketolase (TK) (Scheme 1, B).20 Although a 24% yield was achieved, up to 26% of an isomer (6-deoxy-D-fructose) was also present in the resulting solution. Subsequently, they found that TK could exclusively produces 6-deoxy-L-sorbose when hydroxypyruvate and 4-deoxy-L-threose were used as starting materials (Scheme 1, C).21 The process was improved by coupling the isomerization reaction of 4-deoxy-L-threose from 4-deoxy-L-erythrulose giving a yield up to 35%.21 However, these methods suffer from expensive staring materials, low yields and complicated purification processes. Recently, Shompoosang and co-workers used L-fucose (6-deoxy-L-galactose), a readily available sugar in nature, as starting materials in preparing 6-deoxy-L-sorbose (Scheme, D).18 By this process, L-fucose was isomerized to L-fuculose (6-deoxy-L-tagatose) by L-fucose isomerase, and then 6-deoxy-L-sorbose was epimerized from 6-deoxy-L-tagatose by D-tagatose 3-epimerase (DTE). However, since all aldose-ketose isomerization is very unfavorable for ketose formation, the first step only produce 9% isolated yield. The production was improved by reusing the purified L-fucose several times, but only 27% isolated yield was obtained. The second step produces 50% yield resulting in a final 14% isolated yield of 6-deoxy-L-sorbose with regard to L-fucose. Moreover, this method requires a tedious isomer separation process to obtain 6-deoxy-L-sorbose in pure form.

Scheme 1.

Scheme 1

Enzymatic synthesis of 6-deoxy-L-sorbose. DHAP: dihydroxyacetone phosphate. TK: transketolase. FucI: L-fucose isomerase. DTE: D-tagatose 3-epimerase. HK: fructose kinase. AphA: acid phosphatase. OPME: one-pot multienzyme.

To establish a facile method for 6-deoxy-L-sorbose preparation, we attempt to apply an “isomerization→epimerization→phosphorylation→dephosphorylation” cascade reaction to produce 6-deoxy-L-sorbose from L-fucose directly (Scheme 1, E). FucI catalyzes the isomerization of L-fucose to L-fuculose.22 DTE is a novel epimerase that catalyze the epimerization of ketoses at C-3 position resulting (3S)- and (3R)-interconversion.23-25 These two enzymes have been used to produced 6-deoxy-L-sorbose as mentioned above. Although these two reactions can be carried in one-pot to simplify the synthetic process, the purification of 6-deoxy-L-sorbose from the reaction mixture containing L-fucose, L-fuculose and 6-deoxy-L-sorbose is very difficult and makes this strategy impractical. In this work, the isomerization of L-fucose to L-fuculose, and epimerization of L-fuculose to 6-deoxy-L-sorbose were accurately controlled by coupling with a targeted phosphorylation reaction of 6-deoxy-L-sorbose in one-pot fashion. The selective phosphorylation of 6-deoxy-L-sorbose could drive both reversible reactions towards the formation of the 6-deoxy-L-sorbose 1-phosphate in the first reaction step. However, to achieve the designed scheme, the prerequisite is the availability of a kinase that specifically recognizes 6-deoxy-L-sorbose but not L-fucose and L-fuculose. Otherwise, the products obtained finally will be a mixture containing many isomers (L-fucose and L-fuculose), which are difficult to be separate. By screening the substrate specificity of many kinases, we recently found that fructose kinase (HK) from human, which phosphorylate ketose to ketose 1-phosphate,26 preferred ketose with (3S)-configuration as its substrate.15 In this work, substrate specificity of HK towards 6-deoxy-L-sorbose ((3S)-configuration), L-fucose ((3R)-configuration), and L-fuculose ((3R)-configuration) was studied (see Supplementary Information). 6-deoxy-L-sorbose could serve as the substrate of HK while no detectable activity of HK towards either L-fucose or L-fuculose was observed (Table 1), indicating its potential for one-pot multienzyme (OPME) reaction to produce 6-deoxy-L-sorbose from L-fucose. Indeed, treatment of 6-deoxy-L-sorbose with HK in the presence of ATP as phosphate donor led to complete conversion to 6-deoxy-L-sorbose 1-phosphate after 2 hour at 37 °C.

Table 1.

Substrate specificity of HK towards several deoxy sugarsa

Substrate HK activity (%) C-3 configuration
l-fucose ND R
l-fuculose ND R
6-deoxy-l-sorbose 100 S
a

Substrate specificity was studied by the reactions that were performed at 37°C for 10 minutes in 50 ul reaction mixture containing a Tris-HCl buffer (100 mM, pH 7.5), 20 mM of sugar standards, 20mM of ATP, 5 mM of Mg2+, and 10 ug of enzymes.

ND: no detectable activity was observed.

Having met the prerequisite, other conversion related enzymes including L-fucose isomerase (FucI) from Escherichia coli,27 DTE from Pseudomonas Sp, St-2425, and AphA from Escherichia coli 28 were prepared as described in Supplementary data. To test the potential of HK in OPME reaction, a small scale reaction system (50 ul) containing conversion-related enzymes (FucI, DTE and HK) was performed (reaction group). Reactions without FucI (control 1 group) or DTE (control 2 group) were done as negative controls. The reaction was incubated at 37 °C for 1 hour and monitored by TLC (EtOAc/MeOH/H2O/HOAc=5:2:1.4:0.4). The formation of 6-deoxy-L-sorbose 1-phosphate was observed in the reaction group and no reaction was observed in either control 1 or control 2 (Figure S1), indicating the feasibility of the designed OPME reaction. Preparative reactions were performed in the gram scale. To efficiently convert L-fucose, excess ATP (1.25 equiv) was used. For the convenience of the final purification, no buffer was used. The reaction pH was held near 7.5 using sodium hydroxide as the reaction was ongoing. The reaction was allowed to proceed until no detectable L-fucose was observed by HPLC (conversion ratio exceeding 99%) and thereby making isomer separation unnecessary. 6-deoxy-L-sorbose 1-phosphate was purified by using silver nitrate precipitation method.29 The principle of this method is that silver ions could precipitate ATP and ADP while monophosphate sugars could not be precipitated when the sugars are composed of four or more carbons. Therefore, by applying this selective precipitating ability of siver ions, sugar phosphate can be cleanly and easily separated from adenosine phosphates. Afterwards, the solution was desalted by Bio-Gel P-2 column to afford 6-deoxy-L-sorbose 1-phosphate in 92% yield with reagard to L-fucose. In the second reaction step, the phosphate group of 6-deoxy-L-sorbose 1-phosphate was hydrolyzed by AphA in pH 5.5. Once no detecable sugar phosphate was observed, the reaction was stoped by adding cooled ethanol. The solution was purified by Bio-Rad P-2 column to afford 6-deoxy-L-sorbose in 81 % yield with regard to L-fucose.

The product was confirmed by MS, NMR and HPLC analysis. The predicted peak ([M+Na]+ 187.0582) was well observed on high resolution mass spectrum (see Supplementary Information). NMR spectra are well in accord with the previous reported data.19,30 The reported NMR data (1H-NMR and 13C-NMR) of 6-deoxy-L-sorbose is a mixture contain both α and β furanose isomers. However, we observe that 6.7% of deoxy-L-sorbose exists in aqueous solution as linear chain form (as confirmed by 1H-NMR and 13C-NMR). To analyze the product purity, the product was analyzed by HPLC. No detectable L-fucose (as also confirmed by NMR) and L-fuculose were observed indicated the product purity exceeding 99% (Figure 1).

Figure 1.

Figure 1

HPLC profiles of 6-deoxy-L-sorbose compared with L-fucose (HPX-87H column) and L-fuculose (Sugar-Pak 1 column). The columns were eluted at 60°C with pure water as mobile phase at a flow rate of 0.6 ml/min (ELSD detector).

In summary, using the “isomerization→epimerization→phosphorylation→dephosphoryl ation” cascade reaction as a basis, 6-deoxy-L-sorbose was directly prepared from a readiliy available sugar L-fucose, in 81% isolated yield on the gram scale. By using the silver nitrate precipitation, a desalting column (Bio-Gel P-2 column) allows the product to be isolated with high purity. ATP is also commercially inexpensive owing to increased industrial production over the past decade,31 making the preparation process described herein of particular interest for large-scale production. Moreover, the precipitate of silver-adenosine phosphates complex could be redissolved with ammonium hydroxide, making the recycle of adenosine phosphates and silver ions achievable, which will further reduce the preparation cost when this method was applied on large scale purification. We anticipate that this work will accelerate the progress in understanding both biological roles and synthetic applications of 6-deoxy-L-sorbose.

Supplementary Material

NIHMS807267-supplement.docx (629.3KB, docx)

Table 2.

Enzymatic synthesis of 6-deoxy-l-sorbose from l-fucose using the two-step strategy shown in Scheme 1 a

Starting material Enzymes Intermediate Step 1 yield (%) Product Total yield (%) Scale (mg) Puritya (%)
graphic file with name nihms-807267-t0004.jpg FucI
DTE
HK
AphA
graphic file with name nihms-807267-t0005.jpg 92 graphic file with name nihms-807267-t0006.jpg 81 1059 >99
a

Defined as the percentage of 6-deoxy-l-srobose out of the sum of all possible isomers (as confirmed by HPLC).

Acknowledgments

This work was financially supported National Institute of Health (R01 GM085267 and R01 AI083754).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Supplementary data

Supplementary data associated with this article can be found, in the online version, at

References and notes

  • 1.Beerens K, Desmet T, Soetaert W. Journal of Industrial Microbiology & Biotechnology. 2012;39:823. doi: 10.1007/s10295-012-1089-x. [DOI] [PubMed] [Google Scholar]
  • 2.Granstrom TB, Takata G, Tokuda M, Izumori KJ. Biosci. Bioeng. 2004;97:89. doi: 10.1016/S1389-1723(04)70173-5. [DOI] [PubMed] [Google Scholar]
  • 3.Ahmed Z. Electronic Journal of Biotechnology. 2001;4:13. [Google Scholar]
  • 4.Li B, Varanasi S, Relue P. Green Chem. 2013;15:2149. [Google Scholar]
  • 5.Ishida Y, Kakibuchi K, Kudo R, Izumori K, Tajima S, Akimitsu K, Tanaka K. Acta Hortic. 2012;927:929. [Google Scholar]
  • 6.Wei MH, Li ZJ, Li TH, Wu BL, Liu YP, Qu JY, Li X, Li L, Cai L, Wang PG. Acs Catalysis. 2015;5:4060. [Google Scholar]
  • 7.Wang P, Hong JH, Cooperwood JS, Chu CK. Antiviral Res. 1998;40:19. doi: 10.1016/s0166-3542(98)00041-2. [DOI] [PubMed] [Google Scholar]
  • 8.Oshima H, Kimura I, Izumori K. Journal of bioscience and bioengineering. 2006;101:280. doi: 10.1263/jbb.101.280. [DOI] [PubMed] [Google Scholar]
  • 9.Muniruzzaman S, Pan YT, Zeng Y, Atkins B, Izumori K, Elbein AD. Glycobiology. 1996;6:795. doi: 10.1093/glycob/6.8.795. [DOI] [PubMed] [Google Scholar]
  • 10.Matsuo T, Suzuki H, Hashiguchi M, Izumori K. J Nutr Sci Vitaminol (Tokyo) 2002;48:77. doi: 10.3177/jnsv.48.77. [DOI] [PubMed] [Google Scholar]
  • 11.Chung YM, Hyun Lee J, Youl Kim D, Hwang SH, Hong YH, Kim SB, Jin Lee S, Hye Park CJ. Food Sci. 2012;77:H53. doi: 10.1111/j.1750-3841.2011.02571.x. [DOI] [PubMed] [Google Scholar]
  • 12.Li Z, Gao Y, Nakanishi H, Gao X, Cai L. Beilstein J Org Chem. 2013;9:2434. doi: 10.3762/bjoc.9.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Oshima H, Kimura I, Zumori K. Food Sci Technol Res. 2006;12:137. [Google Scholar]
  • 14.Izumori KJ. Biotechnol. 2005;118:S89. [Google Scholar]
  • 15.Wen L, Huang K, Wei M, Meisner J, Liu Y, Garner K, Zang L, Wang X, Li X, Fang J, Zhang H, Wang PG. Angew Chem Int Ed Engl. 2015;54:12654. doi: 10.1002/anie.201505714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wen L, Zang L, Huang K, Li S, Wang R, Wang PG. Bioorg Med Chem Lett. 2016;26:969. doi: 10.1016/j.bmcl.2015.12.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Schwab W. Molecules. 2013;18:6936. doi: 10.3390/molecules18066936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shompoosang S, Yoshihara A, Uechi K, Asada Y, Morimoto K. J Biosci Bioeng. 2015 doi: 10.1016/j.jbiosc.2015.04.017. [DOI] [PubMed] [Google Scholar]
  • 19.Peters J, Brockamp H-P, Minuth T, Grothus M, Steigel A, Kula M-R, Elling L. Tetrahedron: Asymmetry. 1993;4:1173. [Google Scholar]
  • 20.Hecquet L, Bolte J, Demuynck C. Tetrahedron. 1994;50:8677. [Google Scholar]
  • 21.Hecquet L, Bolte J, Demuynck C. Tetrahedron. 1996;52:8223. [Google Scholar]
  • 22.Heath EC, Ghalambor MA. J Biol Chem. 1962;237:2423. [PubMed] [Google Scholar]
  • 23.Zhang W, Fang D, Zhang T, Zhou L, Jiang B, Mu W. J Agric Food Chem. 2013;61:11468. doi: 10.1021/jf4035817. [DOI] [PubMed] [Google Scholar]
  • 24.Zhang W, Fang D, Xing Q, Zhou L, Jiang B, Mu W. PLoS One. 2013;8:e62987. doi: 10.1371/journal.pone.0062987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Itoh H, Okaya H, Khan AR, Tajima S, Hayakawa S, Izumori K. Bioscience Biotechnology and Biochemistry. 1994;58:2168. [Google Scholar]
  • 26.Asipu A, Hayward BE, O'Reilly J, Bonthron DT. Diabetes. 2003;52:2426. doi: 10.2337/diabetes.52.9.2426. [DOI] [PubMed] [Google Scholar]
  • 27.Seemann JE, Schulz GE. J Mol Biol. 1997;273:256. doi: 10.1006/jmbi.1997.1280. [DOI] [PubMed] [Google Scholar]
  • 28.Rossolini GM, Thaller MC, Pezzi R, Satta G. FEMS Microbiol Lett. 1994;118:167. doi: 10.1111/j.1574-6968.1994.tb06821.x. [DOI] [PubMed] [Google Scholar]
  • 29.Wen L, Huang K, Liu Y, Wang PG. ACS Catalysis. 2016;6:1649. [Google Scholar]
  • 30.Whitesides GM, Mazenod FP, Wong C-H. Google Patents. :1984. [Google Scholar]
  • 31.Zhao H, van der Donk WA. Current opinion in biotechnology. 2003;14:583. doi: 10.1016/j.copbio.2003.09.007. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

NIHMS807267-supplement.docx (629.3KB, docx)

RESOURCES